• Mashup Score: 4

    This population-based cohort study examines the association of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors with the risk of Alzheimer disease and related dementias in patients with type 2 diabetes.

    Tweet Tweets with this article
    • #SGLT2i & #GLP1RA; not *just* for the heart... or kidneys... or diabetes! In ppl w DM2, GLP-1RAs & SGLT2is were associated w ⬇️ risk of Alzheimer disease & related dementias vs other glucose-lowering drugs. @robmentz @gcfmd @JAMA_current @JAMANeuro https://t.co/nP6shAYG7g